Medicinal Products

Lucentis

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Lucentis
Active Substance ranibizumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code S01LA04
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for patients / caregivers
Vodič za bolesnike - dijabetička retinopatija ili dijabetički makularni edem, verzija 1
Vodič za bolesnike neovaskularizacia žilnice, verzija 4
Vodič za bolesnike neovaskularna senilna makularna degeneracija, verzija 4
Vodič za bolesnike začepljenje vene u pozadini mrežnice, verzija 4
Vodiče za bolesnike dijabetički makularni edem, verzija 4
Back